Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001172661-25-001185·Alyeska Investment Group, L.P.
Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock, par value $0.0001 · CUSIP: 03828A101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Alyeska Investment Group, L.P.
Shares: 6,707,497.00 · Class: 5.76%
- Alyeska Fund GP, LLC
Shares: 6,707,497.00 · Class: 5.76%
- Anand Parekh
Shares: 6,707,497.00 · Class: 5.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001185
- Form type
- SCHEDULE 13G
- Filer
- Alyeska Investment Group, L.P.
- CIK
- CIK 1453072
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership